story of the week
Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Extended Therapy for HR+ Early-Stage Breast Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of HR+ Early Stage Breast Cancer Patients for 10 Years of Endocrine Therapy
Clin. Cancer Res 2020 Oct 27;[EPub Ahead of Print], I Noordhoek, K Treuner, H Putter, Y Zhang, J Wong, E Meershoek-Klein Kranenbarg, M Duijm-de Carpentier, CJH van de Velde, CA Schnabel, G LiefersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.